vs
PATHWARD FINANCIAL, INC.（CASH）与Indivior Pharmaceuticals, Inc.（INDV）财务数据对比。点击上方公司名可切换其他公司
Indivior Pharmaceuticals, Inc.的季度营收约是PATHWARD FINANCIAL, INC.的1.3倍（$357.0M vs $276.3M），Indivior Pharmaceuticals, Inc.净利率更高（28.9% vs 26.4%，领先2.5%）
Pathward Financial, Inc.是一家总部位于美国的银行及金融服务企业，其前身为Meta金融集团旗下相关业务主体，2022年母公司将“Meta”商标出售给Meta Platforms后，正式启用现有名称。
Indivior是一家全球专科制药企业，专注于开发和商业化针对阿片类物质使用障碍、酒精依赖及相关精神健康疾病的循证治疗方案，核心市场覆盖北美与欧洲，旗下多款获批疗法服务于医疗需求未被充分满足的患者群体。
CASH vs INDV — 直观对比
营收规模更大
INDV
是对方的1.3倍
$276.3M
净利率更高
INDV
高出2.5%
26.4%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $276.3M | $357.0M |
| 净利润 | $72.9M | $103.0M |
| 毛利率 | — | 82.1% |
| 营业利润率 | — | 22.7% |
| 净利率 | 26.4% | 28.9% |
| 营收同比 | — | — |
| 净利润同比 | — | 390.5% |
| 每股收益（稀释后） | $3.35 | $0.79 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CASHINDV
| Q1 26 | $276.3M | — | ||
| Q4 25 | $173.1M | $357.0M | ||
| Q3 25 | $186.7M | $314.0M | ||
| Q2 25 | $195.8M | $302.0M | ||
| Q1 25 | $274.8M | $266.0M | ||
| Q4 24 | $182.6M | — | ||
| Q3 24 | $179.5M | $307.0M | ||
| Q2 24 | $188.6M | $299.0M |
净利润CASHINDV
| Q1 26 | $72.9M | — | ||
| Q4 25 | $35.2M | $103.0M | ||
| Q3 25 | $38.8M | $42.0M | ||
| Q2 25 | $42.1M | $18.0M | ||
| Q1 25 | $75.0M | $47.0M | ||
| Q4 24 | $30.0M | — | ||
| Q3 24 | $33.5M | $22.0M | ||
| Q2 24 | $44.9M | $-97.0M |
毛利率CASHINDV
| Q1 26 | — | — | ||
| Q4 25 | — | 82.1% | ||
| Q3 25 | — | 73.2% | ||
| Q2 25 | — | 82.8% | ||
| Q1 25 | — | 83.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 78.5% | ||
| Q2 24 | — | 73.6% |
营业利润率CASHINDV
| Q1 26 | — | — | ||
| Q4 25 | 24.6% | 22.7% | ||
| Q3 25 | 25.9% | 13.7% | ||
| Q2 25 | 24.1% | 23.8% | ||
| Q1 25 | 33.2% | 24.8% | ||
| Q4 24 | 19.8% | — | ||
| Q3 24 | 20.9% | 11.4% | ||
| Q2 24 | 27.1% | -39.5% |
净利率CASHINDV
| Q1 26 | 26.4% | — | ||
| Q4 25 | 20.3% | 28.9% | ||
| Q3 25 | 20.8% | 13.4% | ||
| Q2 25 | 21.5% | 6.0% | ||
| Q1 25 | 27.3% | 17.7% | ||
| Q4 24 | 16.4% | — | ||
| Q3 24 | 18.7% | 7.2% | ||
| Q2 24 | 23.8% | -32.4% |
每股收益（稀释后）CASHINDV
| Q1 26 | $3.35 | — | ||
| Q4 25 | $1.57 | $0.79 | ||
| Q3 25 | $1.69 | $0.33 | ||
| Q2 25 | $1.81 | $0.14 | ||
| Q1 25 | $3.14 | $0.38 | ||
| Q4 24 | $1.23 | — | ||
| Q3 24 | $1.34 | $0.16 | ||
| Q2 24 | $1.78 | $-0.72 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $157.6M | $195.0M |
| 总债务越低越好 | $59.5M | — |
| 股东权益账面价值 | $850.7M | $-98.0M |
| 总资产 | $7.1B | $1.2B |
| 负债/权益比越低杠杆越低 | 0.07× | — |
8季度趋势，按日历期对齐
现金及短期投资CASHINDV
| Q1 26 | $157.6M | — | ||
| Q4 25 | $331.2M | $195.0M | ||
| Q3 25 | $120.6M | $445.0M | ||
| Q2 25 | $258.3M | $510.0M | ||
| Q1 25 | $254.2M | $373.0M | ||
| Q4 24 | $597.4M | — | ||
| Q3 24 | $158.3M | — | ||
| Q2 24 | $298.9M | — |
总债务CASHINDV
| Q1 26 | $59.5M | — | ||
| Q4 25 | $33.5M | — | ||
| Q3 25 | $33.5M | — | ||
| Q2 25 | $33.4M | — | ||
| Q1 25 | $33.4M | — | ||
| Q4 24 | $33.4M | — | ||
| Q3 24 | $33.4M | — | ||
| Q2 24 | $33.3M | — |
股东权益CASHINDV
| Q1 26 | $850.7M | — | ||
| Q4 25 | $854.5M | $-98.0M | ||
| Q3 25 | $858.0M | $-207.0M | ||
| Q2 25 | $819.0M | $-257.0M | ||
| Q1 25 | $814.7M | $-285.0M | ||
| Q4 24 | $758.3M | — | ||
| Q3 24 | $822.5M | $-310.0M | ||
| Q2 24 | $748.4M | $-281.0M |
总资产CASHINDV
| Q1 26 | $7.1B | — | ||
| Q4 25 | $7.6B | $1.2B | ||
| Q3 25 | $7.2B | $1.4B | ||
| Q2 25 | $7.2B | $1.5B | ||
| Q1 25 | $7.0B | $1.4B | ||
| Q4 24 | $7.6B | — | ||
| Q3 24 | $7.5B | — | ||
| Q2 24 | $7.5B | — |
负债/权益比CASHINDV
| Q1 26 | 0.07× | — | ||
| Q4 25 | 0.04× | — | ||
| Q3 25 | 0.04× | — | ||
| Q2 25 | 0.04× | — | ||
| Q1 25 | 0.04× | — | ||
| Q4 24 | 0.04× | — | ||
| Q3 24 | 0.04× | — | ||
| Q2 24 | 0.04× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-221.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-245.0M |
| 自由现金流率自由现金流/营收 | — | -68.6% |
| 资本支出强度资本支出/营收 | — | 6.7% |
| 现金转化率经营现金流/净利润 | — | -2.15× |
| 过去12个月自由现金流最近4个季度 | — | $-93.0M |
8季度趋势，按日历期对齐
经营现金流CASHINDV
| Q1 26 | — | — | ||
| Q4 25 | $108.3M | $-221.0M | ||
| Q3 25 | $303.7M | $-39.0M | ||
| Q2 25 | $30.4M | $158.0M | ||
| Q1 25 | $188.3M | $75.0M | ||
| Q4 24 | $-71.7M | — | ||
| Q3 24 | $143.1M | $2.0M | ||
| Q2 24 | $113.2M | $88.0M |
自由现金流CASHINDV
| Q1 26 | — | — | ||
| Q4 25 | $104.1M | $-245.0M | ||
| Q3 25 | $300.3M | $-59.0M | ||
| Q2 25 | $27.7M | $141.0M | ||
| Q1 25 | $184.7M | $70.0M | ||
| Q4 24 | $-73.8M | — | ||
| Q3 24 | $138.8M | $-5.0M | ||
| Q2 24 | $111.0M | $84.0M |
自由现金流率CASHINDV
| Q1 26 | — | — | ||
| Q4 25 | 60.1% | -68.6% | ||
| Q3 25 | 160.9% | -18.8% | ||
| Q2 25 | 14.1% | 46.7% | ||
| Q1 25 | 67.2% | 26.3% | ||
| Q4 24 | -40.4% | — | ||
| Q3 24 | 77.3% | -1.6% | ||
| Q2 24 | 58.8% | 28.1% |
资本支出强度CASHINDV
| Q1 26 | — | — | ||
| Q4 25 | 2.4% | 6.7% | ||
| Q3 25 | 1.8% | 6.4% | ||
| Q2 25 | 1.4% | 5.6% | ||
| Q1 25 | 1.3% | 1.9% | ||
| Q4 24 | 1.1% | — | ||
| Q3 24 | 2.4% | 2.3% | ||
| Q2 24 | 1.2% | 1.3% |
现金转化率CASHINDV
| Q1 26 | — | — | ||
| Q4 25 | 3.08× | -2.15× | ||
| Q3 25 | 7.83× | -0.93× | ||
| Q2 25 | 0.72× | 8.78× | ||
| Q1 25 | 2.51× | 1.60× | ||
| Q4 24 | -2.39× | — | ||
| Q3 24 | 4.27× | 0.09× | ||
| Q2 24 | 2.52× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CASH
| Noninterest Income | $151.2M | 55% |
| Net Interest Income | $125.1M | 45% |
INDV
| Sublocade | $233.0M | 65% |
| Sublingual And Other | $69.0M | 19% |
| Other | $49.0M | 14% |
| Perseris | $6.0M | 2% |
